Pharmacy Freak Editorial Team

Screening models for antidiabetic drugs are essential in B. Pharm education, linking pharmacology, pharmaceutics and drug discovery. This concise guide reviews in vitro models (beta‑cell lines, adipocytes, hepatocytes), in vivo rodent and genetic models (STZ, alloxan, db/db, ob/ob), and modern high-throughput screening, ADMET evaluation, pharmacodynamics, and toxicity screening. Students will learn key assays — insulin … Read more

Introduction: Screening models for antiulcer drugs are essential in experimental pharmacology for B.Pharm students to understand drug discovery and evaluation. These models—such as pylorus ligation, ethanol-induced, NSAID-induced (indomethacin), acetic acid-induced chronic ulcer, stress-induced and cysteamine-induced duodenal ulcer—help assess antisecretory and cytoprotective actions, ulcer index, gastric acidity, mucosal blood flow, and biomarkers (mucin, GSH, MPO, SOD). … Read more

Screening models for cardiovascular drugs are essential for evaluating antiaggregatory and anticoagulant agents during preclinical and early clinical development. B. Pharm students should understand in vitro and in vivo models—platelet aggregation assays (light transmission aggregometry, whole blood impedance), flow cytometry (P‑selectin), thrombin generation assays, chromogenic anti‑Xa, PT/aPTT, and viscoelastic tests (TEG/ROTEM)—along with animal thrombosis models … Read more

Screening models for cardiovascular drugs – antidyslipidemics covers in vitro, in silico and in vivo approaches used to discover and evaluate lipid‑lowering agents. B. Pharm students should understand HMG‑CoA reductase and CETP enzyme assays, LDL uptake in hepatic cell lines, high‑throughput docking, and animal models like Triton WR‑1339, poloxamer‑407, high‑fat diet, ApoE‑/‑ and LDLr‑/‑ mice. … Read more

Screening models for cardiovascular drugs – antiarrhythmics MCQs With Answer This concise introduction covers screening models for cardiovascular drugs, focusing on antiarrhythmics and translational safety pharmacology for B. Pharm students. You will learn key concepts like ion channel assays (hERG, Nav1.5, Cav1.2), patch‑clamp and automated electrophysiology, hiPSC‑derived cardiomyocytes, MEA and optical mapping, isolated tissue and … Read more

Introduction Screening models for cardiovascular drugs—diuretics MCQs With Answer introduces B. Pharm students to essential experimental and clinical approaches used to evaluate diuretics. This concise guide covers in vitro assays (cell-based transport studies, isolated nephron segments), in vivo animal models (rodent urine-volume and electrolyte excretion tests), key targets (NCC, NKCC2, ENaC), pharmacodynamics, pharmacokinetics, biomarkers, safety … Read more

Screening models for cardiovascular drugs—antihypertensives are vital for B.Pharm students to evaluate drug efficacy, safety, and mechanisms affecting blood pressure. This overview highlights in vitro and in vivo models: isolated tissue preparations (aortic rings, wire myograph, Langendorff heart), cell-based assays (HUVEC, vascular smooth muscle cells), and animal models (SHR, DOCA-salt, two-kidney one-clip). Key terms include … Read more

Introduction: Screening models for local anaesthetics are essential in B. Pharm training to evaluate potency, onset, duration, toxicity and mechanism of action. Common keywords include in vitro nerve preparations, patch‑clamp, Langendorff heart, IC50/EC50, pharmacokinetics, pharmacodynamics, structure‑activity relationship (SAR), ester versus amide metabolism, lipophilicity and cardiotoxicity. These models range from isolated nerve or tissue assays and … Read more

Screening models for drugs acting on the eye are essential tools in ocular pharmacology and drug delivery research for B. Pharm students. These models—ranging from in vitro cell cultures and ex vivo corneal/scleral tissues to in vivo animal studies—help evaluate permeability, irritation, toxicity, and pharmacokinetics of ophthalmic candidates. Key concepts include corneal permeability, tear film … Read more